Exagen Inc. (XGN)

Last Closing Price: 2.68 (2026-04-23)

Earnings per Share (EPS) (Diluted) (Annual)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Exagen Inc. (XGN) had Earnings per Share (EPS) (Diluted) of $-0.93 for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$66.58M
$-19.95M
$27.78M
$38.80M
$80.64M
$-14.07M
$-5.83M
$-19.90M
$-19.90M
$-19.95M
$-19.95M
$-19.95M
$-19.95M
$-14.07M
$-10.84M
21.56M
21.56M
$-0.93
Earnings per Share (EPS) (Diluted)
$-0.93
Balance Sheet Financials
$48.89M
$6.94M
$9.13M
$58.02M
$14.16M
$24.22M
$26.41M
$40.57M
$17.45M
$17.45M
$17.45M
22.91M
Cash Flow Statement Financials
$-13.62M
$-0.63M
$24.43M
$22.24M
$32.42M
$10.18M
$2.16M
--
--
Fundamental Metrics & Ratios
3.45
--
--
0.58
1.49
58.28%
-21.13%
-21.13%
-16.28%
-29.89%
-29.97%
$-14.25M
--
--
--
1.15
--
6.13
59.51
-114.34%
-114.34%
-34.39%
-47.88%
$0.76
$-0.66
$-0.63